Nexalin Technology Announces Pricing of $5.2 Million Public Offering
PremiumPress ReleasesNexalin Technology Announces Pricing of $5.2 Million Public Offering
2M ago
Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal
Premium
Press Releases
Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal
2M ago
Nexalin Technology announces ‘positive’ study data in MDD
Premium
The Fly
Nexalin Technology announces ‘positive’ study data in MDD
2M ago
Nexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2,  15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)
PremiumPress ReleasesNexalin Technology Announces Regulatory Approval to Sell Nexalin’s Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)
2M ago
Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th
Premium
Press Releases
Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th
3M ago
Nexalin Technology says FDA reaches consensus on design for HALO studies
Premium
The Fly
Nexalin Technology says FDA reaches consensus on design for HALO studies
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100